Welcome to Seacross Pharmaceuticals Ltd.
Aboutus
Seacross
  • * Aim to be a respected global company dedicated on injectable drugs.
  • * Focused on development & manufacture of high-quality and effective drugs for worldwide healthcare market.
  • * Dynamic and energetic culture of working on customer’s needs by offering flexible and professional service.
  • * As MHRA approved and an EU releaser, own brand drug supplied to more than 1000 EU hospitals.
  • * London subsidiary is responsible for international sales and registration, established business partnerships in more than 80 countries with ongoing product registrations.

Oct. 2010

Established by a group of international pharmaceutical veterans

Sep. 2012

Manufacturing Site completion (construction, commissioning)

Sep. 2013

First validation batches

April 2014

MHRA GMP Approval and in Oct 2014, Chinese GMP approval

July 2015

Irinotecan Injection launched in UK supplying to more than 700 top EU hospitals

March 2016

Docetaxel, Doxorubicin and Zoledronic Acid Injection launched in EU

August 2017

Passed MHRA GMP Re-audit

Oct. 2010

Established by a group of international pharmaceutical veterans

Sep. 2012

Manufacturing Site completion (construction, commissioning)

Sep. 2013

First validation batches

April 2014

MHRA GMP Approval and in Oct 2014, Chinese GMP approval

July 2015

Irinotecan Injection launched in UK supplying to more than 700 top EU hospitals

March 2016

Docetaxel, Doxorubicin and Zoledronic Acid Injection launched in EU

August 2017

Passed MHRA GMP Re-audit
PlantProfile

State of the Art facility incorporated with QbD layout designed by German Engineering Firm MW Zander.

Rigorous GMP compliance in line with EU, FDA and China GMP.

QualitySystem
EU and FDA GMP background & concepts from the onset.
Rigorous and advanced Quality Management System with forefront quality activities.

Products
MORE
Research & Development
In-house product development team for injectable formulations. 
Team with extensive bio-pharmaceutical R&D experience in antibodies. 

Contactus
© Copyright - Clinico fusce blandit sapien eu